Skip to main content

Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.

Publication ,  Journal Article
Anderson, KC; Alsina, M; Bensinger, W; Biermann, JS; Cohen, AD; Devine, S; Djulbegovic, B; Faber, EA; Gasparetto, C; Hernandez-Ilizaliturri, F ...
Published in: J Natl Compr Canc Netw
October 1, 2012

These NCCN Guidelines Insights highlight the important updates/changes specific to the management of Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma. These include the addition of regimens containing novel agents as primary and salvage therapy options, inclusion of the updated summary of response categories and criteria from the sixth international workshop on Waldenström's Macroglobulinemia, and a section on management of peripheral neuropathy in the accompanying discussion.

Duke Scholars

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 1, 2012

Volume

10

Issue

10

Start / End Page

1211 / 1219

Location

United States

Related Subject Headings

  • Waldenstrom Macroglobulinemia
  • Salvage Therapy
  • Rituximab
  • Recurrence
  • Prognosis
  • Practice Guidelines as Topic
  • Peripheral Nervous System Diseases
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Medical Oncology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Anderson, K. C., Alsina, M., Bensinger, W., Biermann, J. S., Cohen, A. D., Devine, S., … NCCN (National Comprehensive Cancer Network), . (2012). Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. J Natl Compr Canc Netw, 10(10), 1211–1219. https://doi.org/10.6004/jnccn.2012.0128
Anderson, Kenneth C., Melissa Alsina, William Bensinger, J Sybil Biermann, Adam D. Cohen, Steven Devine, Benjamin Djulbegovic, et al. “Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.J Natl Compr Canc Netw 10, no. 10 (October 1, 2012): 1211–19. https://doi.org/10.6004/jnccn.2012.0128.
Anderson KC, Alsina M, Bensinger W, Biermann JS, Cohen AD, Devine S, et al. Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. J Natl Compr Canc Netw. 2012 Oct 1;10(10):1211–9.
Anderson, Kenneth C., et al. “Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.J Natl Compr Canc Netw, vol. 10, no. 10, Oct. 2012, pp. 1211–19. Pubmed, doi:10.6004/jnccn.2012.0128.
Anderson KC, Alsina M, Bensinger W, Biermann JS, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Hernandez-Ilizaliturri F, Huff CA, Kassim A, Krishnan AY, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F, Kumar R, Shead DA, NCCN (National Comprehensive Cancer Network). Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. J Natl Compr Canc Netw. 2012 Oct 1;10(10):1211–1219.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 1, 2012

Volume

10

Issue

10

Start / End Page

1211 / 1219

Location

United States

Related Subject Headings

  • Waldenstrom Macroglobulinemia
  • Salvage Therapy
  • Rituximab
  • Recurrence
  • Prognosis
  • Practice Guidelines as Topic
  • Peripheral Nervous System Diseases
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Medical Oncology